BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
8 hedge funds and large institutions have $8.95M invested in BioAmber Inc. in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
13% more capital invested
Capital invested by funds: $7.89M → $8.95M (+$1.06M)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$67.9K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$36.7K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$4.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$295K |
| 2 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$23K |
BIOA.WS Hedge Fund Activity: Q2 2015 in Review
8 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q2 2015, worth a combined $8.95M — up 13% from $7.89M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BIOA.WS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Arrowgrass Capital Partners (US), adding an estimated $67.9K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $295K sold.
- 8 institutional investors held BioAmber Inc. (BIOA.WS) as of Q2 2015, down from 10 in Q1 2015.
- Funds reported $8.95M of BioAmber Inc. stock for Q2 2015, up 13% quarter-over-quarter.
- 1 fund opened new BioAmber Inc. positions in Q2 2015 and 3 closed out, a net change of -2 holders.
- The largest BioAmber Inc. buyer in Q2 2015 was Arrowgrass Capital Partners (US), an estimated $67.9K added.
- The largest BioAmber Inc. seller in Q2 2015 was Monashee Investment Management, an estimated $295K sold.
Based on aggregated 13F filings for Q2 2015.